Celastrol inhibits rheumatoid arthritis through the ROS-NF-κB-NLRP3 inflammasome axis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Celastrol inhibits rheumatoid arthritis through the ROS-NF-κB-NLRP3 inflammasome axis
Authors
Keywords
Celastrol, Rheumatoid arthritis, NLRP3 inflammasome, Nuclear factor-kappa B, Reactive oxygen species, Inflammation
Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 98, Issue -, Pages 107879
Publisher
Elsevier BV
Online
2021-06-18
DOI
10.1016/j.intimp.2021.107879
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rheumatoid arthritis CD14 + monocytes display metabolic and inflammatory dysfunction, a phenotype that precedes clinical manifestation of disease
- (2021) Trudy McGarry et al. Clinical & Translational Immunology
- Chondro-protective effects of celastrol on osteoarthritis through autophagy activation and NF-κB signaling pathway inhibition
- (2020) Kai Feng et al. INFLAMMATION RESEARCH
- Celastrol attenuates collagen-induced arthritis via inhibiting oxidative stress in rats
- (2020) Qiang Gao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Focus on the Role of NLRP3 Inflammasome in Diseases
- (2020) Roberta Fusco et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Celastrol ameliorates P. acnes/LPS-induced liver damage and MSU-induced gouty arthritis via inhibiting K63 deubiquitination of NLRP3
- (2020) Chang-Yu Yan et al. PHYTOMEDICINE
- The involvement of NLRP3 inflammasome in the treatment of Alzheimer’s disease
- (2020) Ya-Shuo Feng et al. AGEING RESEARCH REVIEWS
- Tripterygium wilfordii : An inspiring resource for rheumatoid arthritis treatment
- (2020) Yanqiong Zhang et al. MEDICINAL RESEARCH REVIEWS
- Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
- (2019) Yang Yang et al. Cell Death & Disease
- ACPAs promote IL-1β production in rheumatoid arthritis by activating the NLRP3 inflammasome
- (2019) Xiwen Dong et al. Cellular & Molecular Immunology
- The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
- (2019) Nathan Kelley et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- NLRP3: A promising therapeutic target for autoimmune diseases
- (2018) Hui-Hui Shen et al. AUTOIMMUNITY REVIEWS
- Oxidative stress in autoimmune rheumatic diseases
- (2018) Miranda J. Smallwood et al. FREE RADICAL BIOLOGY AND MEDICINE
- Targeting the NLRP3 inflammasome in inflammatory diseases
- (2018) Matthew S. J. Mangan et al. NATURE REVIEWS DRUG DISCOVERY
- Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome
- (2018) Tao Ding et al. PHYTOMEDICINE
- Orchestration of NLRP3 Inflammasome Activation by Ion Fluxes
- (2018) Tao Gong et al. TRENDS IN IMMUNOLOGY
- Hsp90 inhibition as a means to inhibit activation of the NLRP3 inflammasome
- (2018) Niina Piippo et al. Scientific Reports
- NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis
- (2018) C Guo et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- The role of mitochondria in NLRP3 inflammasome activation
- (2018) Qiuyun Liu et al. MOLECULAR IMMUNOLOGY
- Celastrol inhibits microglial pyroptosis and attenuates inflammatory reaction in acute spinal cord injury rats
- (2018) Wangying Dai et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Chronic Inflammation in Rheumatoid Arthritis and Mediators of Skeletal Muscle Pathology and Physical Impairment: A Review
- (2018) Beatriz Y. Hanaoka et al. ARTHRITIS CARE & RESEARCH
- A new mechanism of inhibition of IL-1β secretion by celastrol through the NLRP3 inflammasome pathway
- (2017) Wenyu Xin et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- NLRP3 p.Q705K and CARD8 p.C10X single nucleotide polymorphisms are not associated with susceptibility to rheumatoid arthritis: a meta-analysis
- (2017) Zhaowen Yang et al. International Journal of Rheumatic Diseases
- Pathogenetic insights from the treatment of rheumatoid arthritis
- (2017) Iain B McInnes et al. LANCET
- Rheumatoid arthritis
- (2016) Josef S Smolen et al. LANCET
- ROS and ROS-Mediated Cellular Signaling
- (2016) Jixiang Zhang et al. Oxidative Medicine and Cellular Longevity
- Mechanism and Regulation of NLRP3 Inflammasome Activation
- (2016) Yuan He et al. TRENDS IN BIOCHEMICAL SCIENCES
- Celastrol Protects against Obesity and Metabolic Dysfunction through Activation of a HSF1-PGC1α Transcriptional Axis
- (2015) Xinran Ma et al. Cell Metabolism
- NLRP3 at the interface of metabolism and inflammation
- (2015) Moritz Haneklaus et al. IMMUNOLOGICAL REVIEWS
- Anti-inflammation effect of methyl salicylate 2-O-β-D-lactoside on adjuvant induced-arthritis rats and lipopolysaccharide (LPS)-treated murine macrophages RAW264.7 cells
- (2015) Xue Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Inflammasomes and human autoimmunity: A comprehensive review
- (2015) Chin-An Yang et al. JOURNAL OF AUTOIMMUNITY
- Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis
- (2015) Christianna Choulaki et al. ARTHRITIS RESEARCH & THERAPY
- The interplay between inflammation and metabolism in rheumatoid arthritis
- (2015) M S Chimenti et al. Cell Death & Disease
- NLRP3 inflammasome and its inhibitors: a review
- (2015) Bo-Zong Shao et al. Frontiers in Pharmacology
- Comparison ofTripterygium wilfordiiHook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial
- (2014) Qian-wen Lv et al. ANNALS OF THE RHEUMATIC DISEASES
- Effective treatment of rat adjuvant-induced arthritis by celastrol
- (2012) R. Cascão et al. AUTOIMMUNITY REVIEWS
- Evaluation of complete Freund’s adjuvant-induced arthritis in a Wistar rat model
- (2012) U. Snekhalatha et al. ZEITSCHRIFT FUR RHEUMATOLOGIE
- Interleukin-18: A Mediator of Inflammation and Angiogenesis in Rheumatoid Arthritis
- (2011) Michael V. Volin et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Celastrol Suppresses Angiogenesis-Mediated Tumor Growth through Inhibition of AKT/Mammalian Target of Rapamycin Pathway
- (2010) X. Pang et al. CANCER RESEARCH
- Characterization of Celastrol to Inhibit Hsp90 and Cdc37 Interaction
- (2009) Tao Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now